Depression

App Helps Patients with Depression, Psychiatrists Manage Mood, Activity Levels

COLUMBIA, Mo. ― Approximately 16 million American adults are affected by depression. However, many patients see a psychiatrist only once every two to three months. Recognizing that patients often forget how their moods vary between visits, a team from the University of Missouri, Missouri University of Science and Technology and the Tiger Institute for Health

Exploring the brain’s role in stress-induced anxiety​​​

July 23, 2015 By Jim Dryden BRUCHAS LABORATORY Neurons in the mouse brain appear green as they produce a substance that makes them sensitive to light. The red marks the presence of norepinephrine, which surges under stress. Calming a neural circuit in the brain can alleviate stress in mice, according to new research that could

Device delivers drugs to brain via remote control​​

Technology demonstrated for the first time in mice July 16, 2015 By Jim Dryden ALEX DAVID JEREZ ROMAN PHOTO Tiny, implantable devices are capable of delivering light or drugs to specific areas of the brain, potentially improving drug delivery to targeted regions of the brain and reducing side effects. Eventually, the devices may be used

Finding the body clock’s molecular reset button

Researchers from McGill and Concordia discover mechanism involved in adjusting rhythms of circadian clock PUBLISHED: 27 APR 2015 An international team of scientists has discovered what amounts to a molecular reset button for our internal body clock. Their findings reveal a potential target to treat a range of disorders, from sleep disturbances to other behavioral,

Mindfulness-based therapy could offer an alternative to antidepressants for preventing depression relapse

Researchers from Plymouth University Peninsula Schools of Medicine and Dentistry are part of a team led by the University of Oxford, who have carried out new research that suggests mindfulness-based cognitive therapy (MBCT) could provide an alternative non-drug treatment for people who do not wish to continue long-term antidepressant treatment. The results are published in

NIH award funds research into tiny devices that shine light on brain disorders

Washington University in St. Louis, by Jim Dreyden ~ November 12, 2013 To better understand and one day provide improved treatments for depression, addiction and anxiety, researchers at Washington University School of Medicine in St. Louis are using tiny, electronic devices to identify and map neural circuits in the brain. The innovative work has been

Study looks at safety, effectiveness of generics for treating depression

Washington University in St. Louis, by Jim Dreyden ~ November 4, 2013 Researchers at Washington University School of Medicine in St. Louis are studying the quality, effectiveness and safety of generic drugs used to treat depression. The research is supported by the U.S. Food and Drug Administration (FDA) and is the only study of its

Rockville biotech tests stem cells for depression

Monday, July 2, 2012 By: Gazette staff Neuralstem, the Rockville company that's developing a stem cell treatment for patients with amyotrophic lateral sclerosis, has begun testing the safety of its treatment for major depressive disorder. The compound, NSI-189, stimulates new neuron growth in the brain's hippocampus region, which scientists think is involved in depression and